KX2-361
N/A
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameKX2-361
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAthenex Inc
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesHangzhou Converd Co LtdGuangzhou Xiangxue Pharmaceutical Co LtdGuangzhou Xiangxue New Drug Development Co Ltd
Inactive CompaniesAthenex Inc
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A